|
RGNX Regenxbio Inc 1590877 |
| Balance Sheet |
|
Current Assets
|
$186,516,000.00 |
|
Assets
|
$341,894,000.00 |
|
Current Liabilities
|
$71,110,000.00 |
|
Liabilities
|
$320,812,000.00 |
|
Equity
|
$21,082,000.00 |
|
Shares Out
|
51617000.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-76,186,000.00 |
|
Investing Cash Flow
|
$70,588,000.00 |
| Market Analysis |
Market Cap
|
$522,364,040.00 |
|
Price
|
$9.55 |
|
BVPS
|
0.41 |
|
PB
|
24.68 |
|
EPS
|
-1.72 |
|
PS
|
26.81 |
|
FCF
|
$-77,421,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:30 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:27 |
|
| Apr |
May |
Jun |
| 2026-03-05 |
-1.30 |
|
|
2026-05-14 |
-1.72 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-07 |
-1.38 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-06 |
-1.20 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view RGNX documents filed with the SEC.
RGNX Filings
Clear
